APA (7th ed.) Citation

K, D., A, A., NA, A., N, B., S, C., EP, C., . . . EM, H. (2021). Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode. Journal of medicinal chemistry, 64(18), 13780. https://doi.org/10.1021/acs.jmedchem.1c01102

Chicago Style (17th ed.) Citation

K, Down, et al. "Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode." Journal of Medicinal Chemistry 64, no. 18 (2021): 13780. https://doi.org/10.1021/acs.jmedchem.1c01102.

MLA (9th ed.) Citation

K, Down, et al. "Discovery of GSK251: A Highly Potent, Highly Selective, Orally Bioavailable Inhibitor of PI3Kδ with a Novel Binding Mode." Journal of Medicinal Chemistry, vol. 64, no. 18, 2021, p. 13780, https://doi.org/10.1021/acs.jmedchem.1c01102.